Rat studies are extremely fallible when trying to prove that something harms a human. Not just because it's another species, that is sometimes the reason why, but also because we humans aren't living as lab rats. Some humans are living like lab rats, and it impairs their metabolic machinery so otherwise beneficial nutrients become hazardous. It seems absurd to me to keep blaming the macronutrients when they can't be metabolized properly, as if it's their fault. Let me explain.
Metabolic syndrome: Wonky metabolic machinery and abnormalities of metabolic functioning. A nutrient needs to go somewhere, but it can't because the body is so dysfunctional, so it goes off track and damages something, going where it's not supposed to. Hyperglycemia is an example of poor glucose metabolism, the glucose reaches a concentration where it damages the circulatory system and everything in it. Lipotoxicity is where fatty acids can't be cleared quickly from the blood or the cells and it builds up, overloading the cells, causing them to downregulate insulin sensitivity, and causing the fatty acids to be metabolized to harmful things, because they metabolic pathways aren't overloaded like the normal healthy ones. Neither of these maladies is caused by the macronutrient in question but by the inability to metabolize it, and so why should we think that BCAAs are any different?
Some examples of high fat reductionism refuted:
The dreaded high fat rodent murder diet doesn't actually cause metabolic syndrome in rats! It only does if the diet is deficient in omega-3 fatty acids or other nutrients. http://www.sciencemag.org/content/237/4817/885.abstract The mechanism is likely that omega-3 fatty acids are PPAR a and g binding ligands and facilitate peroxisomal beta oxidation so that they can prevent lipid overload. The long chain saturated fatty acids need to be broken down in peroxisomes, this means that palmitic acid and stearic acid get a bad reputation because when the peroxisomes don't do their job PA and SA are the most lipotoxic (because they really really really can't be metabolized). Also lowering inflammation from the get-go would really allow the cells to activate thermogenesis of fatty acids because there would be less leptin resistance impairing uncoupling of fatty acids. This also helps to clear the excess fatty acids. Lowering inflammation would also allow for better AMPK action, which also governs fatty acid metabolism. All of this allows the fatty acids to be metabolized quickly and efficiently so they don't build up or spill places where they will cause harm.
And you could do this with a wide variety of nutrients, I'm sure. And exercise http://www.ncbi.nlm.nih.gov/pubmed/20631645 Anything that prevents inflammation, oxidative damage to important metabolic structures, activates gene expression in a pro-metabolic way, etc. If that "high fat" diet was sufficiently low in omega-6 fatty acids we could probably expect to see better metabolism of saturated fatty acids too. But oh no, "high fat" bad.
Even though all of this knowledge is available people still think that feeding rats processed goo with synthetic vitamins, keeping them cooped up in a cage and stressed is a reliable model for how fatty acids behave in humans. Give-me-a-break. I can't exactly refute the BCAA thing (in rats) right now but let's see them demonstrate the same thing in healthy, exercising, nourished humans. Except that the biggest sources of BCAAs in humans prevent insulin resistance http://www.ncbi.nlm.nih.gov/pubmed/20377924 So if the best source of BCAAs in the human diet fails to cause insulin resistance, in fact the opposite is true, how can we even think of trying to extrapolate isolated BCAAs in a malnourished rat's diet to humans?
Yeah, I don't know either :D
I really doubt that this finding is applicable to healthy humans. And it may indeed be a situation where rats are just the wrong species to study.
Edit: and what do you know, even pure BCAA supplementation in exercising humans has no effect on body fat or glucose metabolism http://www.ncbi.nlm.nih.gov/pubmed/9051392